Method for modulating gene expression by modifying the cpg content
AssigneeGeneart AG
InventorsFRANK NOTKA, MARCUS GRAF, DORIS LEIKAM, RALF WAGNER, DAVID RAAB
Life of this patent
Estimating the term…
Abstract
The invention relates to nucleic acid modifications for a directed expression modulation by the targeted insertion or removal of CpG dinucleotides. The invention also relates to modified nucleic acids and expression vectors.
Claims24
Method for the targeted modulation of the gene expression, comprising the steps:
- (i) Provision of a target nucleic acid sequence to be expressed,
- (ii) Modification of the target nucleic acid sequence, in which the number of CpG dinucleotides present in the target nucleic acid sequence is raised using the degeneracy of the genetic code to increase the gene expression, or is lowered to reduce the gene expression,
- (iii) Cloning of the thereby modified target nucleic acid sequence with a modified number of the CpG dinucleotides in a suitable expression vector in operative coupling with a suitable transcription control sequence,
- (iv) Expression of the modified target nucleic acid sequence in a suitable expression system.
5-7. (canceled)
11-22. (canceled)
Modified nucleic acid with a region capable of transcription that can be expressed in an expression system, and which is derived from a wild-type sequence, in which the region capable of transcription is modified so that it is codon-optimised in relation to the employed expression system, and so that the number of CpG dinucleotides is increased compared to the codon-optimised sequence derived from the wild-type sequence, by using the degeneracy of the genetic code.
(canceled)
37-42. (canceled)
Dependencies are inferred from the claim text.